GETI.B

184.25

+1.04%↑

EKTA.B

56.5

+1.25%↑

AMBEA

127.8

-2.29%↓

ARJOB

24.92

-0.24%↓

MSON.B

11.85

+3.49%↑

GETI.B

184.25

+1.04%↑

EKTA.B

56.5

+1.25%↑

AMBEA

127.8

-2.29%↓

ARJOB

24.92

-0.24%↓

MSON.B

11.85

+3.49%↑

GETI.B

184.25

+1.04%↑

EKTA.B

56.5

+1.25%↑

AMBEA

127.8

-2.29%↓

ARJOB

24.92

-0.24%↓

MSON.B

11.85

+3.49%↑

GETI.B

184.25

+1.04%↑

EKTA.B

56.5

+1.25%↑

AMBEA

127.8

-2.29%↓

ARJOB

24.92

-0.24%↓

MSON.B

11.85

+3.49%↑

GETI.B

184.25

+1.04%↑

EKTA.B

56.5

+1.25%↑

AMBEA

127.8

-2.29%↓

ARJOB

24.92

-0.24%↓

MSON.B

11.85

+3.49%↑

Kodu・Aktsiate loetelu・Attendo AB

Attendo AB

Suletud

98.8 -0.4

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

97.4

Max

99.5

Põhinäitajad
By Trading Economics
Sissetulek	161M 494M
Müük	27M 4.8B
P/E Sektori keskmine	18.672 57.833
Aktsiakasum	1.65
Dividenditootlus	1.8
Kasumimarginaal	10.3
Töötajad	33,000
EBITDA	-79M 1.1B

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	1.80% 2.47%

Turustatistika
By TradingEconomics
Turukapital	11M 15B
Eelmine avamishind	99.2
Eelmine sulgemishind	98.8

Attendo AB Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. märts 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23. märts 2026, 22:55 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23. märts 2026, 21:51 UTC

Omandamised, ülevõtmised, äriostud

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23. märts 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23. märts 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23. märts 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23. märts 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23. märts 2026, 22:42 UTC

Market Talk

Uudisväärsed sündmused

Global Equities Roundup: Market Talk

23. märts 2026, 22:42 UTC

Market Talk

Uudisväärsed sündmused

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23. märts 2026, 22:40 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23. märts 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23. märts 2026, 22:22 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23. märts 2026, 22:18 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23. märts 2026, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23. märts 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23. märts 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. märts 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23. märts 2026, 21:10 UTC

Uudisväärsed sündmused

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23. märts 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk

Tulu

Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Attendo AB Prognoos

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Attendo AB

Attendo AB (publ) provides health and care services in Scandinavia and Finland. The company offers nursing homes for people with dementia or physical care requirements; home care services, including care, meals, cleaning, laundry, evening and night, and home health care services for older people; homes for people of various ages with a range of disabilities or care needs; respite and companion services, as well as short term accommodation; homes and other care services for people with neuropsychiatric and psychosocial impairments; and social-worker supported foster care, crisis and emergency accommodation, HVB-homes, addiction care, and various forms of supportive housing services. Attendo AB (publ) was founded in 1985 and is headquartered in Danderyd, Sweden.